2022
DOI: 10.1111/ene.15645
|View full text |Cite
|
Sign up to set email alerts
|

Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study

Abstract: Background and purpose:The prevalence of Huntington disease (HD) has increased over time; however, there is a lack of up-to-date evidence documenting the economic burden of HD by disease stage. This study provides an estimate of the annual direct medical, nonmedical, and indirect costs associated with HD from participants in the Huntington's Disease Burden of Illness (HDBOI) study in five European countries and the USA. Methods:The HDBOI is a retrospective, cross-sectional study. Data collection was conducted … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 15 publications
0
7
0
Order By: Relevance
“…The average medical cost for HD in China is 3,265.65 Euros per year. This is lower than the estimates in Western countries including Italy, Spain, Germany, France, the USA, the UK, and Canada, where annual costs range from 4,167 Euros in France to 27,743 Euros in the USA [3, 4]; however, it is higher than the estimate in Peru, where the cost was 531.885 Euros in 2020 [9]. The average direct non-medical cost in China is 805.82 Euros, lower than the estimates in Italy, Spain, Germany, France, the USA, the UK, as well as in Peru where the cost was 5,734.44 Euros [4].…”
Section: Discussionmentioning
confidence: 75%
See 4 more Smart Citations
“…The average medical cost for HD in China is 3,265.65 Euros per year. This is lower than the estimates in Western countries including Italy, Spain, Germany, France, the USA, the UK, and Canada, where annual costs range from 4,167 Euros in France to 27,743 Euros in the USA [3, 4]; however, it is higher than the estimate in Peru, where the cost was 531.885 Euros in 2020 [9]. The average direct non-medical cost in China is 805.82 Euros, lower than the estimates in Italy, Spain, Germany, France, the USA, the UK, as well as in Peru where the cost was 5,734.44 Euros [4].…”
Section: Discussionmentioning
confidence: 75%
“…The disease typically manifests in individuals between the ages of 30 and 50 years, with a median life expectancy of 15 years post-diagnosis [2, 3]. Despite ongoing research, no treatment has been found yet to halt or slow the progression of HD [3, 4]. Current medical interventions aim to alleviate symptoms and optimise physical functions [3, 4].…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations